Nadine Miller
Medical · Minneapolis, MNNPI 1811929870
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations.
Across 40 payments — averaging $22.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$178
- Incyte Corporation$126
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$76
- Regeneron Healthcare Solutions, Inc.$75
- Novartis$51
- LEO Pharma Inc.$50
- plus $348 from 13 others
What the payments were for
- Food & beverage$88998%
- Education$152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 3 | $178 |
| Incyte Corporation | 4 | $126 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $76 |
| Regeneron Healthcare Solutions, Inc. | 5 | $75 |
| Novartis | 2 | $51 |
| LEO Pharma Inc. | 3 | $50 |
| Amgen | 3 | $50 |
| E.r. Squibb & Sons, L.L.C. | 3 | $48 |
| Lilly USA, LLC | 3 | $41 |
| Sun Pharmaceutical Industries Inc. | 2 | $34 |
| Johnson & Johnson | 2 | $28 |
| Genentech USA, Inc. | 1 | $25 |
| Boehringer Ingelheim | 1 | $23 |
| Biowound Solutions, Inc. | 1 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| Biofrontera Inc. | 1 | $15 |
| AbbVie | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $14 |
How this compares
$904 in reported general payments places this provider in the 80th percentile of 202 medical providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 66 | $3,984 |
| Metronidazole | 47 | $2,212 |
| Ketoconazole | 108 | $2,194 |
| Doxycycline Hyclate | 52 | $1,827 |
| Azelaic Acid | 13 | $1,486 |
| Clobetasol Propionate | 36 | $1,109 |
| Triamcinolone Acetonide | 89 | $784 |
| ValacyclovirValacyclovir Hcl | 37 | $779 |
| Clindamycin Phosphate | 16 | $622 |
| Desonide | 13 | $385 |
| Fluocinonide | 12 | $374 |
| Fluocinolone Acetonide Oil | 11 | $297 |
| Mometasone Furoate | 11 | $205 |
| Hydrocortisone | 23 | $200 |
| Mupirocin | 14 | $76 |
Paid to pharmacies, not to this prescriber.
Other medical in Minneapolis
- Steven AtkinsonMinneapolis$2K
- Kimberly McCaughanMinneapolis$2K
- Ashley KonstantinidesMinneapolis$929
- Anne HendricksonMinneapolis$767
- Kristina ThissenRogers$178K
- Cynthia KonrathMinnetonka$95K
- Tyler JohnsonWaconia$28K
- Eliza AbrahamWhite Bear Lake$19K
- Tobie MeyerMaple Grove$13K
- Emily BurkmanWhite Bear Lake$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.